
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SLC26A3 CRISPR/Cas9 KO Plasmid (h) | sc-403891 | 20 µg | $397.00 |
SLC26A3 encodes a membrane anion exchanger (also known as DRA) that mediates electroneutral Cl⁻/HCO₃⁻ exchange at the apical surface of epithelial cells, with prominent roles in intestinal fluid and electrolyte absorption. By regulating bicarbonate secretion and chloride uptake, SLC26A3 contributes to luminal pH control and epithelial transport processes that interface with CFTR-dependent ion handling and mucosal homeostasis. Disruption or dysregulation of SLC26A3 has been linked to congenital chloride diarrhea and broader phenotypes involving epithelial barrier function and inflammatory signaling in the gastrointestinal tract. Its expression and activity are therefore relevant to studies of epithelial differentiation, transport physiology, and inflammation-associated remodeling of the gut microenvironment.
SLC26A3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SLC26A3 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SLC26A3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SLC26A3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SLC26A3 protein expression.
This CRISPR knockout system enables efficient generation of SLC26A3-deficient cell models for investigation of SLC26A3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.